GlobeImmune

GlobeImmune, Gilead Hep B drug fails in mid-stage study
Yahoo/Reuters
Wed, 05/27/15 - 09:53 am
GlobeImmune
Gilead Sciences
hepatitis B
GS-4774
IPO Preview: GlobeImmune
Seeking Alpha
Fri, 06/27/14 - 09:53 am
IPOs
GlobeImmune
Tarmogen
Eager biotechs eye $133M in IPOs as a frenzied quarter closes
Fierce Biotech
Tue, 03/18/14 - 11:10 am
IPOs
biotech
Aldeyra Therapeutics
GlobeImmune
Agile Therapeutics
Celgene may purchase $4.9M in additional shares of Globelmmune
The Fly on the Wall
Mon, 08/20/12 - 10:28 am
Celgene
GlobeImmune
M&A
10 Promising Therapeutic Vaccines
Fierce Vaccines
Thu, 10/27/11 - 01:40 pm
vaccines
ICT-107
glioblastoma
ImmunoCellular
VGX-3100
Inovio
cervical cancer
MAGE-A3
GSK
skin cancer
lung cancer
NeuVax
breast cancer
RXi Pharmaceuticals
Antigen Express
AE37
Nexvax2
celiac disease
ImmusanT
ADXS-HPV
head and neck cancer
Advaxis
GI-4000
GlobeImmune
pancreatic cancer
PEV7
Pevion Biotech
GlobeImmune, Gilead team up on hepatitis B treatment
Bizjournals.com
Tue, 10/25/11 - 09:21 am
Gilead
GlobeImmune
hepatitis B
Tarmogens
5 promising pancreatic cancer drugs
Fierce Biotech
Thu, 10/13/11 - 01:23 pm
Amgen
Takeda
Ganitumab
KAEL-GemVax
GV1001
HyperAcute Pancreas
NewLink Genetics
GI-4000
GlobeImmune
MM-398
Merrimack Pharmaceuticals
pancreatic cancer
2009's Top Sector for Venture Investment: Biotech
Seeking Alpha
Mon, 01/25/10 - 09:20 am
venture capital
GlobeImmune
Ironwood
GenVec
AstraZeneca
Novartis
deCODE Genetics
Celgene and GlobeImmune enter cancer drug pact
Yahoo/AP
Fri, 05/15/09 - 10:04 am
Celgene
GlobeImmune
partnerships